Global Inhaled Nitric Oxide NO Delivery Systems Market by Type (General Type, Intelligent Type), By Application (Infant, Adult) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
The Global Inhaled Nitric Oxide NO Delivery Systems Market size was valued at $2.8 billion in 2018 and is projected to grow at a CAGR of 5.3% from 2021 to 2028. The growth in this market will be supported by the rising prevalence of chronic respiratory diseases such as asthma and COPD, increasing awareness about the benefits of inhaled nitric oxide therapy among patients with acute or chronic respiratory conditions, improving product innovation in terms of cost-effective delivery systems for inhalation drugs that can provide accurate doses adjusted on body weight or disease severity and growing demand from emerging economies.
Inhaled Nitric Oxide Delivery Systems are the medical devices that provide inhaled nitric oxide therapy to patients with acute or chronic respiratory conditions. They come in two types: general type and intelligent type. These devices are used to treat respiratory conditions which include pulmonary hypertension, chronic obstructive pulmonary disease, and other lung diseases. These devices can also be used in cardiology procedures for the treatment of coronary artery disease when combined with a balloon catheter or stent placement.
On the basis of Types, the market is segmented into General Type and Intelligent Type. General type devices are further segmented into nasal types, oral types, and others (nasal hoods). On the other hand. intelligent type is primarily split on the basis of inhaler device, nebulizer device, and system-inhalers.
General Type:
The general type is an inhaler that delivers nitric oxide gas directly into the lungs without using electronics while intelligent types provide inhaled nitric oxide therapy through electronic controls by monitoring patient's breathing patterns and adjusting Nitric Oxide concentration accordingly. General type devices are used to deliver a continuous flow of nitric oxide gas from an external tank. They typically provide stable levels of oxygen and humidity which is required for the therapy treatment.
Intelligent Type:
Intelligent type delivery systems allow precise adjustment in terms of dose based on weight or disease severity. This is done by incorporating a microprocessor that can control the dosage delivered through inhalation. The intelligent type also has built-in sensors that monitor a patient's breathing patterns with instantaneous feedback information to adjust if necessary before delivering nitric oxide gas into the lungs.
On the basis of Applications, the market is segmented into Infant Applications & Adult applications.
Infant:
The use of inhaled nitric oxide NO delivery systems in infant applications is expected to witness considerable growth during the forecast period from 2021 to 2028. This can be attributed primarily due to the increasing prevalence of respiratory tract infections and other related diseases, which are substantially worsening with time. As a result, physicians prescribe health care professionals such as neonatologists or pediatricians for the treatment of newborns suffering from these ailments by administering prophylactic medications that act directly on the lungs (e.g., bronchodilators) or through indirect effects (e.g., steroids). To prevent infants from premature airway closure at birth-a condition known as persistent pulmonary hypertension syndrome-physicians often administer inhaled nitric oxide NO delivery system. A NO delivery system is a device, which delivers an aerosolized drug (e.g., nitric oxide) to the respiratory tract for therapeutic purposes.
Adult:
The global inhaled nitric oxide NO delivery systems market for adult application is expected to grow at a CAGR of over 27% from 2021 to 2028. This growth can be attributed to the use of inhaled nitric oxide NO delivery systems for managing respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary vasculitis disorders as well as bronchiectasis. In addition, it has been found that inhalers are easy and comfortable to use by patients compared with nebulizers or metered-dose inhalers.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. The North American region is expected to be the largest market for inhaled nitric oxide NO delivery systems in 2021. This growth can be attributed to factors like increasing awareness about this technology among physicians as well as a growing number of respiratory diseases afflicting adults such as COPD and asthma which are more prevalent in countries like America than in other regions.
Growth Factors For The Global Inhaled Nitric Oxide NO Delivery Systems Market:
- The growing popularity of OncoNOx® and other NO products in the treatment of asthma and COPD. More than 50% of patients with chronic obstructive pulmonary disease (COPD) will experience an exacerbation at some point during their lifetime.
- Proven performance as a bronchodilator, vasopressor, systemic anticoagulant agent, antioxidant, and ischemic preconditioning agent. Nitric oxide has been used extensively to treat respiratory disorders such as pulmonary artery hypertension or acute lung injury.
- Increasing awareness about NO therapy among physicians- Physicians have increased familiarity with nitric oxide over time because it can be administered in various forms according to patient needs.
- Low-cost devices captured a sizable share of the market due to their affordability and availability.
Up Market Research published a new report titled “Inhaled Nitric Oxide NO Delivery Systems Market research report which is segmented by Types (General Type, Intelligent Type), By Applications (Infant, Adult), By Players/Companies International Biomedical, Praxair (NoxBox), Getinge, SLE, VERO Biotech”.
Report Scope
Report Attributes | Report Details |
Report Title | Inhaled Nitric Oxide NO Delivery Systems Market Research Report |
By Type | General Type, Intelligent Type |
By Application | Infant, Adult |
By Companies | International Biomedical, Praxair (NoxBox), Getinge, SLE, VERO Biotech |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 241 |
Number of Tables & Figures | 169 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Inhaled Nitric Oxide NO Delivery Systems Market Report Segments:
The market is segmented by Type General Type, Intelligent Type and By Application Infant, Adult.
Some of the companies that are profiled in this report are:
- International Biomedical
- Praxair (NoxBox)
- Getinge
- SLE
- VERO Biotech
Inhaled Nitric Oxide NO Delivery Systems Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Inhaled Nitric Oxide NO Delivery Systems Market
Overview of the regional outlook of the Inhaled Nitric Oxide NO Delivery Systems Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Inhaled Nitric Oxide NO Delivery Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Inhaled Nitric Oxide NO Delivery Systems Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. General Type
2. Intelligent Type
7. By Application:1. Infant
2. Adult
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Inhaled Nitric Oxide NO Delivery Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Inhaled Nitric Oxide NO Delivery Systems Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Inhaled Nitric Oxide NO Delivery Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Inhaled Nitric Oxide NO Delivery Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Inhaled Nitric Oxide NO Delivery Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Inhaled Nitric Oxide NO Delivery Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Inhaled Nitric Oxide NO Delivery Systems Market Size & Forecast, 2018-2028
4.5.1 Inhaled Nitric Oxide NO Delivery Systems Market Size and Y-o-Y Growth
4.5.2 Inhaled Nitric Oxide NO Delivery Systems Market Absolute $ Opportunity
Chapter 5 Global Inhaled Nitric Oxide NO Delivery Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Type
5.2.1 General Type
5.2.2 Intelligent Type
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Inhaled Nitric Oxide NO Delivery Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Applications
6.2.1 Infant
6.2.2 Adult
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Inhaled Nitric Oxide NO Delivery Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Inhaled Nitric Oxide NO Delivery Systems Analysis and Forecast
9.1 Introduction
9.2 North America Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Type
9.6.1 General Type
9.6.2 Intelligent Type
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Applications
9.10.1 Infant
9.10.2 Adult
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Inhaled Nitric Oxide NO Delivery Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Type
10.6.1 General Type
10.6.2 Intelligent Type
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Applications
10.10.1 Infant
10.10.2 Adult
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Inhaled Nitric Oxide NO Delivery Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Type
11.6.1 General Type
11.6.2 Intelligent Type
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Applications
11.10.1 Infant
11.10.2 Adult
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Inhaled Nitric Oxide NO Delivery Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Type
12.6.1 General Type
12.6.2 Intelligent Type
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Applications
12.10.1 Infant
12.10.2 Adult
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Inhaled Nitric Oxide NO Delivery Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Type
13.6.1 General Type
13.6.2 Intelligent Type
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Inhaled Nitric Oxide NO Delivery Systems Market Size Forecast by Applications
13.10.1 Infant
13.10.2 Adult
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Inhaled Nitric Oxide NO Delivery Systems Market: Competitive Dashboard
14.2 Global Inhaled Nitric Oxide NO Delivery Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 International Biomedical
14.3.2 Praxair (NoxBox)
14.3.3 Getinge
14.3.4 SLE
14.3.5 VERO Biotech